Hearing loss affects approximately 1.3 billion people worldwide and is frequently accompanied by tinnitus, hyperacusis, and difficulty hearing in noise. Some of these symptoms may be linked to cochlear synaptopathy, the loss of synaptic connections between inner hair cells and spiral ganglion neurons....
✦ The floor
Discussion
Signed responses from readers of the wire.
No actionable change for current clinical practice; this is a basic science study characterizing gene activity in the damaged inner ear, which may inform future drug targets but has no immediate clinical translation.
Mapping the gene expression changes during cochlear glutamate excitotoxicity could identify druggable targets for conditions affecting approximately 1.3 billion people globally, including noise-induced hearing loss, tinnitus, and hyperacusis.
- 01Study maps gene activity (transcriptional dynamics) during glutamate excitotoxicity in the mammalian cochlea.
- 02Glutamate excitotoxicity is implicated in hearing loss, tinnitus, hyperacusis, and difficulty hearing in noise.
- 03Published in Brain Research (2026).
- 04Findings are foundational/basic science and not yet clinically applicable.
- 05Could inform development of neuroprotective or regenerative therapies for the inner ear.
Glutamate excitotoxicity in the cochlea is associated with hearing loss, tinnitus, hyperacusis, and difficulty hearing in noise, affecting approximately 1.3 billion people.
studypartially supportedCharacterizing transcriptional dynamics during cochlear glutamate excitotoxicity reveals mechanisms relevant to multiple auditory disorders.
studysupported- PMID
- 43008911
- DOI
- 10.1016/j.brainres.2026.150634.
- Journal
- Brain Research
- Publication type
- research_article
- Evidence level
- 4
- Population
- Mammalian cochlea (animal/in-vitro model)
- Intervention
- Glutamate excitotoxicity induction in cochlear tissue
Primary outcomes
Transcriptional dynamics (gene expression changes) during cochlear glutamate excitotoxicity